12:00 AM
 | 
Apr 08, 2013
 |  BC Week In Review  |  Company News  |  Deals

Qurient, Roche, Institut Pasteur Korea deal

Roche partnered with not-for profit Institut Pasteur Korea and the institute's spin-off Qurient to discover and develop drug candidates for infectious diseases. Under the two-year deal, the partners will collaborate on areas that include assay development, compound screening and target identification. The...

Read the full 186 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >